Drug Enforcement D-0181-2023

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Status

Terminated

Classification

Class I

Report Date

February 1, 2023

Termination Date

February 26, 2024

Product Information

Product description
Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940
Product quantity
321,246 tablets
Reason for recall
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide in the USA.

Location & Firm

Recalling firm
Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
Address
184 Liberty Corner Rd, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0181-2023
Event ID
91259
Recall initiation date
December 6, 2022
Center classification date
January 25, 2023
Code info
a) Lots EJ2218, EJ2219, EJ2220, Exp 09/2023; b) Lot 953D, Exp 05/2025
More code info
—